Shopping Cart
- Remove All
- Your shopping cart is currently empty
7-Hydroxymethotrexate is the major metabolite of Methotrexate.Methotrexate is an inhibitor of folic acid, inhibiting dihydrofolate reductase, which prevents the conversion of folic acid to tetrahydrofolate, and inhibiting DNA synthesis.Methotrexate is also an inhibitor of metabolism.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $312 | In Stock | |
5 mg | $749 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,530 | In Stock | |
50 mg | $2,450 | In Stock |
Description | 7-Hydroxymethotrexate is the major metabolite of Methotrexate.Methotrexate is an inhibitor of folic acid, inhibiting dihydrofolate reductase, which prevents the conversion of folic acid to tetrahydrofolate, and inhibiting DNA synthesis.Methotrexate is also an inhibitor of metabolism. |
In vitro | With an affinity for DHFR markedly lower (>100-fold) than Methotrexate (MTX), 7-Hydroxymethotrexate (7-OHMTX)[1]. |
In vivo | Administered intravenously at a dose of 4 mg/kg, 7-Hydroxymethotrexate (7-OHMTX) exhibits a terminal half-life of 97.2 min and a total clearance value of 9.6 mL/min•mg[1]. |
Alias | NSC-380963, NSC380963, NSC-380962, NSC380962, NSC 380963, NSC 380962 |
Molecular Weight | 470.44 |
Formula | C20H22N8O6 |
Cas No. | 5939-37-7 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 0.66 mg/mL (1.4 mM), Sonification is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.